Table 2 Biodistribution of radioactivity after concomitant intravenous injection of (+)-[ ¹²⁵ I]IV-OH and (+)-[ ¹³¹ I] p IV in tumor-bearing mice

1.28 (0.13)*

1.04 (0.10)*

0.43 (0.09)**

0.00 (0.00)*

9.55 (0.64)**

5.45 (0.70)

2.57 (0.41)

0.06 (0.04)**

7.82 (0.32)*

9.80 (0.94)**

2.81 (0.33)*

0.06 (0.03)*

35.01 (2.83)*

15.30 (1.80)

4.89 (0.87)**

0.04 (0.01)*

5.26 (0.61)*

7.96 (0.72)*

4.84 (0.95)

0.14 (0.02)*

8.11 (1.24)

1.84 (0.11)*

0.60 (0.12)*

0.01 (0.02)*

25.04 (2.40)*

12.80 (0.97)*

2.94 (0.49)*

0.01 (0.01)*

9.74 (1.59)*

1.85 (0.18)*

0.63 (0.11)*

0.01 (0.02)*

3.57 (0.40)*

0.78 (0.05)*

0.27(0.00)**

0.01 (0.01)*

1.18 (0.36)

0.62 (0.18)

0.55 (0.25)

0.03 (0.02)*

5.14 (0.50)*

1.04 (0.08)*

0.22 (0.02)*

0.00 (0.00)*

2.20 (0.58)

0.45 (0.03)*

0.26 (0.10)

0.01 (0.01)*

0.45 (0.03)

0.28 (0.02)

0.17 (0.01)

0.50 (0.01)

7.20 (0.40)

5.79 (0.37)

6.46 (3.42)

6.81 (2.60)

9.83 (0.39)

13.31 (1.25)

13.05 (0.46)

10.28 (0.59)

18.47 (1.59)

11.72 (1.90)

7.37 (0.89)

6.15 (0.30)

4.31 (0.78)

5.14 (0.12)

3.20 (0.13)

2.59 (0.24)

8.12 (1.09)

8.99 (1.00)

4.04 (0.30)

2.52 (0.23)

16.58 (1.82)

21.94 (2.50)

27.35 (0.24)

27.36 (0.70)

26.10 (3.39)

13.13 (3.28)

6.59 (0.56)

3.01 (0.46)

8.66 (0.81)

5.55 (0.70)

2.11 (0.37)

0.96 (0.07)

1.07 (0.32)

0.73 (0.26)

0.62 (0.19)

0.49 (0.06)

6.02 (0.74)

6.47 (0.73)

4.12 (0.30)

2.22 (0.10)

2.03 (0.53)

1.62 (0.22)

0.72 (0.29)

0.42 (0.03)